Cough Monitoring Study
|ClinicalTrials.gov Identifier: NCT01263626|
Recruitment Status : Completed
First Posted : December 21, 2010
Last Update Posted : June 8, 2015
The aim of the study is to establish the accuracy of a new device designed specifically to record and detect cough episodes.
Cough is an important defense mechanism of the respiratory tract. The presence of chronic cough may indicate the presence of underlying diseases, including reflux. Despite the increased number of patients suffering from cough in the ENT and GI practice, to date, there has been no method/device to objectively assess the frequency of cough episodes in a given patient.
PULMOTRACK-CC, manufactured by KarmelSonix (Haifa, Israel), has recently introduced an innovative device that is able to record cough episodes and then automatically detect and count them with the help of a specific software program. This study will assess the accuracy of this novel cough monitoring and counting technology and validate potential clinical use in patients with chronic cough.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||33 participants|
|Observational Model:||Case Control|
|Official Title:||Monitoring Cough Device - Step 1 and 2|
|Study Start Date :||November 2010|
|Primary Completion Date :||January 2012|
|Study Completion Date :||December 2014|
Cough as Primary Complaint
- Accuracy of Cough Device [ Time Frame: 24 hours post device placement ]The aim of the study is to establish the accuracy of a new device designed specifically to record and detect cough episodes.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01263626
|United States, Tennessee|
|Vanderbilt University Medical Center|
|Nashville, Tennessee, United States, 37232|
|Principal Investigator:||Michael Vaezi, MD, PhD||Vanderbilt University Medical Center|